I got pneumonia in the US and was admitted to hospital. Not ICU but private room due to company insurance.
I was there for a little under 24 hours (I couldn't stand it so I checked myself out) - cost $US36k
I expect ICU would be worse.
At the volumes that RemL would need to be produced to make any sort of impact to death rates in the US, if it was administered to anyone admitted to hospital with severe breathing difficulties (i.e way before significant lung damage and ventilator support), I expect it would pay for itself with each day it shortened in hospitalisation and produce even stronger mortality reductions than the recent results which were for the gravely ill.
I got pneumonia in the US and was admitted to hospital. Not ICU...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.020(1.73%) |
Mkt cap ! $1.341B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.17 | $16.67M | 14.04M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 54704 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.020 ( 3.40 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.17 | 2927691 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| MSB (ASX) Chart |